Search

everythinglearnresearchcommunity

for

Search:↓

Mice with human gene experienced hair loss when treated with DHT.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Blocking a specific protein signal can make hair grow on mouse nipples.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Androgens may block hair growth signals, targeting this could treat hair loss.

Cedrol from Platycladus orientalis leaves may promote hair growth effectively, especially in female mice.

Changing Wnt signaling can lead to more or less hair growth and might help treat hair loss and skin conditions.

GLI2 increases follistatin production in human skin cells.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Hair loss requires customized treatments based on its various causes and types.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Spironolactone might help protect against severe lung problems in COVID-19 patients.